Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma
Authors:
Open Access
- 20 October 2020
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 20 (1) , 1-15
Abstract
Background: Immune-related genes is closely related to the occurrence and prognosis of head and neck squamous cell carcinoma (HNSCC). At the same time, immune-related genes have great potential as prognostic markers in many types of cancer. The prognosis of HNSCC is still poor currently, and it may be effective to predict the clinical outcome of HNSCC by immunogenic analysis. Methods: RNASeq and clinical follow-up information were downloaded from The Cancer Genome Atlas (TCGA), the MINiML format GSE65858 chip expression data was downloaded from NCBI, and immune-related genes was downloaded from the InnateDB database. Immune-related genes in 519 HNSC patients were integrated from TCGA dataset. By using multivariate COX analysis and Lasso regression, robust immune-related gene pairs (IRGPs) that predict clinical outcomes of HNSCC were identified. Finally, a risk prognostic model related to immune gene pair was established and verified by clinical features, test sets and GEO external validation set. Results: A total of 699 IRGPs were significantly correlated with the prognosis of HNSCC patients. Fourteen robust IRGPs were finally obtained by Lasso regression and a prognostic risk prediction model was constructed. Risk score of each sample were calculated based on Risk models and divided into the high-risk group (Risk-H) and low Risk group (Risk-L). Risk models were able to stratify the risk in patients with TNM Stage, Age, gender, and smoking history, and the AUC > 0.65 in training set and test set, shows that 14-IRGPs signature in patients with HNSCC has excellent classification performance. In addition, 14-IRGPs had the highest average C index compared with the prognostic characteristics and T, N, and Age of the 3 previously reported HNSCC. Conclusion: This study constructed 14-IRGPs as a novel prognostic marker for predicting survival in HNSCC patients.Keywords
This publication has 30 references indexed in Scilit:
- Gene promoter methylation signature predicts survival of head and neck squamous cell carcinoma patientsEpigenetics, 2016
- Assessing the clinical utility of cancer genomic and proteomic data across tumor typesNature Biotechnology, 2014
- Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysisThe Lancet Oncology, 2013
- Clinical and biological implications of driver mutations in myelodysplastic syndromesBlood, 2013
- Biology of Human Papillomavirus Infections in Head and Neck CarcinogenesisHead and Neck Pathology, 2012
- Cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2012
- Molecular signatures database (MSigDB) 3.0Bioinformatics, 2011
- Induction Therapy in the Modern Era of Combined-Modality Therapy for Locally Advanced Head and Neck CancerSeminars in Oncology, 2008
- DAVID Knowledgebase: a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysisBMC Bioinformatics, 2007
- GSEA-P: a desktop application for Gene Set Enrichment AnalysisBioinformatics, 2007